Zushima Plaster for Treating Knee Osteoarthritis

• Status: Completed
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to further evaluate the clinical efficacy and safety of Zushima plaster for patients in knee osteoarthrosis post-marketing.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Collaborators: Beijing Hospital; Beijing Hospital of Traditional Chinese Medicine; Beijing Jishuitan Hospital; Beijing Shijitan Hospital; Beijing Shijitan Hospital, Capital Medical University; Gansu Provincial Hospital; General Hospital of Beijing Military Area; Shanghai Municipal Hospital of Traditional Chinese Medicine
• Treatments: Indomethacin

Criteria

Inclusion Criteria:

• Ages 40-75;

• Unilateral or bilateral knee OA, confirmed radiographically;

• Patients taking oral NSAIDs prior to the breakthrough period will be permitted;

• VAS pain score is or above 20mm.

Exclusion Criteria:

• Knee is swollen and hot;

• Allergic to any ingredient in Girald Daphne Bark Plaster (Girald Daphne Bark, Lithargite, Linseed oil, Red lead) ;

• Congestive Heart Failure and Edema;

• Advanced renal disease;

• Knee joint skin is burst or skin disease or allergies.